Pfizer (PFE)

27.57
+0.03 (0.11%)
NYSE · Last Trade: Nov 20th, 2:58 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Most-Active S&P 500 Stocks: Ford, Super Micro, Pfizer Lead Session Volumechartmill.com
Via Chartmill · November 19, 2026
Pfizer Will Pay Its 352nd Straight Quarterly Dividend on Dec. 7. Here's What It Would Take to Break the Streak.fool.com
Pfizer's dividend streak spans 88 years, and it would take a perfect storm to end it.
Via The Motley Fool · November 19, 2026
S&P 500 Most Active Stocks on Nov. 18: AES Leads Volume, Freeport-McMoRan Drops 6.45%chartmill.com
Via Chartmill · November 18, 2026
Novavax Eyes New Partnerships as Sanofi Advances COVID-Flu Vaccine Trialmarketbeat.com
Novavax (NASDAQ:NVAX) is looking to expand partnerships around its vaccine technology while advancing a potential C. difficile vaccine and supporting partner Sanofi’s development of a combination COVID-19 and flu shot, executives said at the Jefferies 2026 Global Healthcare Conference in London. CE
Via MarketBeat · November 17, 2026
Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenuefool.com
J&J's quarterly sales have climbed with few setbacks, while Pfizer's have swung between $13.7 billion and $17.8 billion over eight quarters.
Via The Motley Fool · November 17, 2026
S&P 500 Most Active Stocks for Nov. 17, 2026chartmill.com
Via Chartmill · November 17, 2026
Pfizer CEO Sees Growth Beyond Patent Cliff, Highlights Monthly Obesity Drug Ambitionsmarketbeat.com
Pfizer (NYSE:PFE) expects recently launched medicines and a growing pipeline to help it emerge from a period of patent expirations with high single-digit growth, CEO Albert Bourla said at the Jefferies London Healthcare Conference. Bourla said the loss-of-exclusivity period is expected to last anot
Via MarketBeat · November 17, 2026
2 Stocks With Dividend Yields of 4% or More to Buy in Novemberfool.com
These two stocks can provide reliable income for your portfolio for years to come.
Via The Motley Fool · November 16, 2026
Today's Most-Active S&P 500 Stocks: Ford Leads Volume as SMCI and Micron Fallchartmill.com
Via Chartmill · November 16, 2026
5 Dividend Stocks With High Yields That Are Safer Than You Might Thinkfool.com
A high yield is a sign that investors are worried about a business, but sometimes that concern is overwrought.
Via The Motley Fool · November 14, 2026
Novo Nordisk vs. Pfizer: Does a Weight Loss or Cancer Focused Pharma Stock Make a Better Buy for 2027?fool.com
Novo Nordisk's obesity-drug dominance faces rising rivals, while Pfizer's cheaper valuation and cash flow tell a different story for income-minded investors.
Via The Motley Fool · November 14, 2026
Axsome Therapeutics vs. Moderna: Which Biotech Innovator Stock Is a Better Buy for 2027?fool.com
Axsome's revenue has climbed about 54% while Moderna's net losses run deep, but a steep valuation gap may tip the scales for patient investors.
Via The Motley Fool · November 14, 2026
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?fool.com
These healthcare dividend stocks appeal to investors in different ways.
Via The Motley Fool · November 14, 2026
Pfizer Just Raised Its 2026 Revenue Forecast by $1.5 Billion. Is the High-Yield Stock a Buy Right Now?fool.com
Pfizer isn't out of the woods yet, but it is proving it remains a well-run drugmaker.
Via The Motley Fool · November 13, 2026
2 Bargain Stocks to Buy With $1,000 in Novemberfool.com
Stocks are finally settling down following a few weeks of extreme volatility. Use this lull as an entry point before more investors realize many of these names are currently on sale at a great price.
Via The Motley Fool · November 13, 2026
Exelixis Has 2 Major Catalysts Coming by March 2027. Here's What Investors Should Watch.fool.com
These catalysts could impact growth down the road.
Via The Motley Fool · November 13, 2026
Most Active S&P 500 Stocks: KDP, Ford, AT&T Lead Today's Sessionchartmill.com
Via Chartmill · November 12, 2026
3 Magnificent Dividend Stocks Yielding 4% or More to Buy in Novemberfool.com
These three blue chip dividend stocks offer higher yields while standing out in terms of dividend coverage and growth.
Via The Motley Fool · November 10, 2026
Worried About a Market Crash? These 3 High-Yielding Stocks Can Be Safe Long-Term Optionsfool.com
These stocks pay as much as 5.9% in dividends.
Via The Motley Fool · November 10, 2026
S&P 500 Most Active Stocks in Today's Session: SMCI, AT&T, Ford Lead Volumechartmill.com
Via Chartmill · November 10, 2026
Pfizer Hits a New 52-Week High. Here's Why It's Not Too Late to Buy the Stockfool.com
This surprising healthcare stock has been outperforming the markets this year.
Via The Motley Fool · November 10, 2026
Medicus Pharma (MDCX) Q3 2026 Earnings Call Transcriptfool.com
A SkinJect SPAC plan and melanoma focus mark the next phase.
Via The Motley Fool · November 9, 2026
Most-Active S&P 500 Stocks in Today's Sessionchartmill.com
Via Chartmill · November 9, 2026
Why Pfizer Believes It Can Be a Leader in the GLP-1 Market, Even Though Its Drug May Not Debut Until 2028fool.com
Investors shouldn't count out Pfizer in the GLP-1 market just yet.
Via The Motley Fool · November 9, 2026
Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trialsfool.com
Everyone is talking about the GLP-1 battle between Eli Lilly and Novo Nordisk, but Pfizer wants in on the fight, too.
Via The Motley Fool · November 7, 2026